Mozobil (Genzyme Corporation)
Welcome to the PulseAid listing for the Mozobil drug offered from Genzyme Corporation. This Hematopoietic Stem Cell Mobilizer [EPC],Increased Hematopoietic Stem Cell Mobilization [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Genzyme Corporation |
| NON-PROPRIETARY NAME: | PLERIXAFOR |
| SUBSTANCE NAME: | PLERIXAFOR |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Hematopoietic Stem Cell Mobilizer [EPC],Increased Hematopoietic Stem Cell Mobilization [PE] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2008-12-15 |
| END MARKETING DATE: | 0000-00-00 |
Mozobil HUMAN PRESCRIPTION DRUG Details:
| Item Description | Mozobil from Genzyme Corporation |
| LABELER NAME: | Genzyme Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 24(mg/1.2mL) |
| START MARKETING DATE: | 2008-12-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 58468-0140_2b6cc6a4-9e7b-4066-9936-e23a753b7547 |
| PRODUCT NDC: | 58468-0140 |
| APPLICATION NUMBER: | NDA022311 |
Other PLERIXAFOR Pharmaceutical Manufacturers / Labelers:
